Published in Biol Psychiatry on December 21, 2007
The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull (2009) 4.69
Treatment of tobacco dependence in mental health and addictive disorders. Can J Psychiatry (2009) 1.91
Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial. JAMA (2014) 1.44
Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis. Addiction (2016) 1.43
Efficacy of initiating tobacco dependence treatment in inpatient psychiatry: a randomized controlled trial. Am J Public Health (2013) 1.38
Interventions to Address Medical Conditions and Health-Risk Behaviors Among Persons With Serious Mental Illness: A Comprehensive Review. Schizophr Bull (2015) 1.21
Efficacy of pharmacotherapies for short-term smoking abstinance: a systematic review and meta-analysis. Harm Reduct J (2009) 1.06
The co-occurrence of cigarette smoking and bipolar disorder: phenomenology and treatment considerations. Bipolar Disord (2011) 1.05
Linkage analysis of adult height in a large pedigree from a Dutch genetically isolated population. Hum Genet (2009) 1.04
A tobacco reconceptualization in psychiatry: toward the development of tobacco-free psychiatric facilities. Am J Addict (2010) 1.04
Treatment of tobacco dependence in people with mental health and addictive disorders. Curr Psychiatry Rep (2012) 0.99
Comparison of available treatments for tobacco addiction. Curr Psychiatry Rep (2010) 0.99
Predictors of early abstinence in smokers with schizophrenia. J Clin Psychiatry (2008) 0.97
Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia. Psychopharmacology (Berl) (2011) 0.95
Smoking cessation and reduction in people with chronic mental illness. BMJ (2015) 0.95
Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia. Drug Alcohol Depend (2009) 0.94
The relationship between reward-based learning and nicotine dependence in smokers with schizophrenia. Psychiatry Res (2012) 0.90
Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled study. Drug Alcohol Depend (2011) 0.90
A Review of Smoking Cessation in Bipolar Disorder: Implications for Future Research. J Dual Diagn (2012) 0.88
An Open Trial of Relapse Prevention Therapy for Smokers With Schizophrenia. J Dual Diagn (2013) 0.87
Combination pharmacotherapy for stopping smoking: what advantages does it offer? Drugs (2010) 0.87
A Review of Varenicline's Efficacy and Tolerability in Smoking Cessation Studies in Subjects with Schizophrenia. J Addict Res Ther (2011) 0.86
Readiness to quit as a predictor for outcomes of smoking-reduction programme with transdermal nicotine patch or bupropion in a sample of 308 patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci (2014) 0.85
Clinical characteristics of heavy and non-heavy smokers with schizophrenia. Schizophr Res (2012) 0.85
Is implementation of the 5 A's of smoking cessation at community mental health centers effective for reduction of smoking by patients with serious mental illness? Am J Addict (2009) 0.84
Comparison of two intensities of tobacco dependence counseling in schizophrenia and schizoaffective disorder. J Subst Abuse Treat (2010) 0.83
On blending practice and research: the search for commonalities in substance abuse treatment. Subst Abus (2006) 0.83
Treatment of tobacco use disorders in smokers with serious mental illness: toward clinical best practices. Harv Rev Psychiatry (2015) 0.83
Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practice. Addiction (2013) 0.82
A double-blind randomized clinical trial of different doses of transdermal nicotine patch for smoking reduction and cessation in long-term hospitalized schizophrenic patients. Eur Arch Psychiatry Clin Neurosci (2012) 0.81
Interventions for the metabolic syndrome in schizophrenia: a review. Ther Adv Endocrinol Metab (2012) 0.80
Treatment of comorbid tobacco use in people with serious mental illness. J Psychiatry Neurosci (2009) 0.79
Antidepressants for cognitive impairment in schizophrenia--a systematic review and meta-analysis. Schizophr Res (2014) 0.78
Predictors of abstinence and changes in psychiatric symptoms in a pooled sample of smokers with schizophrenia receiving combination pharmacotherapy and behavioral therapy for smoking cessation. J Clin Psychopharmacol (2009) 0.78
The effects of bupropion on negative symptoms in schizophrenia. Iran J Pharm Res (2014) 0.77
Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers. CNS Drugs (2015) 0.77
Smoking Topography Characteristics of Very Low Nicotine Content Cigarettes, With and Without Nicotine Replacement, in Smokers With Schizophrenia and Controls. Nicotine Tob Res (2016) 0.77
Understanding the problems developing a healthy living programme in patients with serious mental illness: a qualitative study. BMC Psychiatry (2014) 0.77
Combination Extended Smoking Cessation Treatment Plus Home Visits for Smokers With Schizophrenia: A Randomized Controlled Trial. Nicotine Tob Res (2016) 0.77
Effectiveness of a multi-component Smoking Cessation Support Programme (McSCSP) for patients with severe mental disorders: study design. Int J Environ Res Public Health (2013) 0.75
A smoking ban in psychiatric units: threat or opportunity? Ment Health Fam Med (2008) 0.75
Exploring Issues of Comorbid Conditions in People Who Smoke. Nicotine Tob Res (2016) 0.75
Effectiveness of a Culturally-Tailored Smoking Cessation Intervention for Arab-American Men. Int J Environ Res Public Health (2017) 0.75
Pharmacotherapy of Co-Occurring Schizophrenia and Substance Use Disorders. Curr Addict Rep (2014) 0.75
Biologic Commonalities between Mental Illness and Addiction. Prim psychiatry (2009) 0.75
Achieving Smoking Cessation in Individuals with Schizophrenia: Special Considerations. CNS Drugs (2017) 0.75
Smoking cessation in severe mental ill health: what works? an updated systematic review and meta-analysis. BMC Psychiatry (2017) 0.75
Predictors of smoking reduction outcomes in a sample of 287 patients with schizophrenia spectrum disorders. Eur Arch Psychiatry Clin Neurosci (2015) 0.75
Abstinence and Use of Community-Based Cessation Treatment After a Motivational Intervention Among smokers with Severe Mental Illness. Community Ment Health J (2016) 0.75
The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull (1987) 51.07
Smoking and mental illness: A population-based prevalence study. JAMA (2000) 14.17
Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res (2003) 11.72
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med (1999) 10.62
A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med (1997) 9.73
Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry (2004) 8.45
Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev (2004) 7.89
The Contemplation Ladder: validation of a measure of readiness to consider smoking cessation. Health Psychol (1991) 7.88
Reliability of a timeline method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations. Br J Addict (1988) 6.20
A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res (2005) 5.78
Survival probabilities (the Kaplan-Meier method). BMJ (1998) 3.98
Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict (2005) 3.89
Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry (1995) 3.30
Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch Gen Psychiatry (2002) 2.47
Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch Gen Psychiatry (2005) 2.28
Bupropion is a nicotinic antagonist. J Pharmacol Exp Ther (2000) 2.26
A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia. J Clin Psychopharmacol (2005) 2.07
Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. Am J Psychiatry (1998) 1.95
A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biol Psychiatry (2002) 1.86
Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am J Psychiatry (2000) 1.82
Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology (2000) 1.77
A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. J Clin Psychopharmacol (2007) 1.66
Smoking cessation treatment for patients with schizophrenia. Am J Psychiatry (1998) 1.64
A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Nicotine Tob Res (2001) 1.23
Inhibition of CYP2D6 activity by bupropion. J Clin Psychopharmacol (2005) 1.19
Use of random-sequence riboflavin as a marker of medication compliance in chronic schizophrenics. Schizophr Res (1991) 0.98
Atypical antipsychotic dosing: the effect of smoking and caffeine. Psychiatr Serv (2004) 0.94
The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia. Int J Nurs Stud (2004) 0.91
A double-blind placebo-controlled cross over trial of bupropion in smoking reduction in schizophrenia. Schizophr Res (2005) 0.85
Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry (2003) 7.11
Can food be addictive? Public health and policy implications. Addiction (2011) 6.27
Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol (2010) 4.77
Behavioral impulsivity predicts treatment outcome in a smoking cessation program for adolescent smokers. Drug Alcohol Depend (2006) 3.61
Compulsive features in behavioural addictions: the case of pathological gambling. Addiction (2011) 3.28
Introduction to behavioral addictions. Am J Drug Alcohol Abuse (2010) 3.22
Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol (2006) 3.02
Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology (2009) 2.60
Mindfulness-based treatments for co-occurring depression and substance use disorders: what can we learn from the brain? Addiction (2010) 2.50
Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry (2006) 2.50
Preliminary validity and reliability testing of a structured clinical interview for pathological gambling. Psychiatry Res (2004) 2.35
Cue-induced brain activity changes and relapse in cocaine-dependent patients. Neuropsychopharmacology (2006) 2.32
Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch Gen Psychiatry (2005) 2.28
The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochem Pharmacol (2007) 2.22
Individuals family history positive for alcoholism show functional magnetic resonance imaging differences in reward sensitivity that are related to impulsivity factors. Biol Psychiatry (2010) 2.16
Broadening our horizon: response to commentaries. Addiction (2012) 2.11
Impulse control disorders in adult psychiatric inpatients. Am J Psychiatry (2005) 2.09
Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacology (2002) 2.08
Health correlates of recreational gambling in older adults. Am J Psychiatry (2004) 2.08
Pretreatment brain activation during stroop task is associated with outcomes in cocaine-dependent patients. Biol Psychiatry (2008) 2.04
Gender differences in the associations between past-year gambling problems and psychiatric disorders. Soc Psychiatry Psychiatr Epidemiol (2007) 2.02
Investigating the behavioral and self-report constructs of impulsivity domains using principal component analysis. Behav Pharmacol (2009) 1.90
Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study. Biol Psychiatry (2004) 1.90
Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Mov Disord (2009) 1.89
Stress decreases the ability to resist smoking and potentiates smoking intensity and reward. J Psychopharmacol (2010) 1.86
A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biol Psychiatry (2002) 1.86
Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity. Psychopharmacology (Berl) (2011) 1.77
Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study. Ann Neurol (2010) 1.77
Problematic Internet use: clinical implications. CNS Spectr (2007) 1.74
Impulse control disorders in Parkinson disease: a multicenter case--control study. Ann Neurol (2011) 1.73
An FMRI study of the effects of psychostimulants on default-mode processing during Stroop task performance in youths with ADHD. Am J Psychiatry (2009) 1.70
Psychiatric correlates of gambling in adolescents and young adults grouped by age at gambling onset. Arch Gen Psychiatry (2004) 1.68
Mindfulness training and stress reactivity in substance abuse: results from a randomized, controlled stage I pilot study. Subst Abus (2009) 1.62
Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology (Berl) (2009) 1.62
The neurobiology of substance and behavioral addictions. CNS Spectr (2006) 1.59
Effects of topiramate on smoking in patients with schizoaffective disorder, bipolar type. J Clin Psychopharmacol (2008) 1.58
Neurodevelopment, impulsivity, and adolescent gambling. J Gambl Stud (2003) 1.57
Video-gaming among high school students: health correlates, gender differences, and problematic gaming. Pediatrics (2010) 1.56
Gender differences in adolescent gambling. Ann Clin Psychiatry (2006) 1.51
An initial study of neural responses to monetary incentives as related to treatment outcome in cocaine dependence. Biol Psychiatry (2011) 1.50
Shared brain vulnerabilities open the way for nonsubstance addictions: carving addiction at a new joint? Ann N Y Acad Sci (2010) 1.46
The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study. Psychiatry Res (2009) 1.46
Diminished frontostriatal activity during processing of monetary rewards and losses in pathological gambling. Biol Psychiatry (2012) 1.44
Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial. JAMA (2011) 1.44
Effects of tobacco smoking on neuropsychological function in schizophrenia in comparison to other psychiatric disorders and non-psychiatric controls. Am J Addict (2013) 1.44
Stealing among high school students: prevalence and clinical correlates. J Am Acad Psychiatry Law (2011) 1.43
Sensory gating deficits during the mid-latency phase of information processing in medicated schizophrenia patients. Psychiatry Res (2004) 1.43
Gender differences in adolescent marijuana use and associated psychosocial characteristics. J Addict Med (2011) 1.42
Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients. Drug Alcohol Depend (2003) 1.41
Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: a preliminary study. J Clin Psychopharmacol (2008) 1.41
Compulsive aspects of impulse-control disorders. Psychiatr Clin North Am (2006) 1.37
A targeted review of the neurobiology and genetics of behavioural addictions: an emerging area of research. Can J Psychiatry (2013) 1.37
Simulated apoptosis/neurogenesis regulates learning and memory capabilities of adaptive neural networks. Neuropsychopharmacology (2004) 1.36
Medication-related impulse control and repetitive behaviors in Parkinson's disease. Curr Opin Neurol (2007) 1.35
Binge eating disorder and food addiction. Curr Drug Abuse Rev (2011) 1.33
Survey of clinician attitudes toward smoking cessation for psychiatric and substance abusing clients. J Addict Dis (2008) 1.33
Impulse-control disorders in adolescent psychiatric inpatients: co-occurring disorders and sex differences. J Clin Psychiatry (2007) 1.33
Neural correlates of stress- and food cue-induced food craving in obesity: association with insulin levels. Diabetes Care (2012) 1.32
Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study. Psychopharmacology (Berl) (2010) 1.29
Impulsive sensation seeking, parental history of alcohol problems, and current alcohol and tobacco use in adolescents. J Addict Med (2008) 1.28
Prenatal cocaine exposure and gray matter volume in adolescent boys and girls: relationship to substance use initiation. Biol Psychiatry (2013) 1.27
Long-term follow-up of impulse control disorders in Parkinson's disease. Mov Disord (2008) 1.27
Are black-white differences in females' body dissatisfaction decreasing? A meta-analytic review. J Consult Clin Psychol (2006) 1.27
Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management. Paediatr Drugs (2004) 1.26
Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial. Int Clin Psychopharmacol (2003) 1.25
Decreased ventral striatal activity with impulse control disorders in Parkinson's disease. Mov Disord (2010) 1.22
To do or not to do? The complexities of addiction, motivation, self-control, and impulsivity. Am J Psychiatry (2007) 1.21
Problematic Internet use and health in adolescents: data from a high school survey in Connecticut. J Clin Psychiatry (2011) 1.20
Monetary reward processing in obese individuals with and without binge eating disorder. Biol Psychiatry (2013) 1.19
Tossing the baby out with the bathwater after a brief rinse? The potential downside of dismissing food addiction based on limited data. Nat Rev Neurosci (2012) 1.19
Self-reported gambling-related suicidality among gambling helpline callers. Psychol Addict Behav (2005) 1.19
A preliminary study of the neural effects of behavioral therapy for substance use disorders. Drug Alcohol Depend (2011) 1.18
Gambling, health and age: data from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Addict Behav (2007) 1.16
Predicting response to opiate antagonists and placebo in the treatment of pathological gambling. Psychopharmacology (Berl) (2008) 1.16
A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotinic receptor mechanisms. Schizophr Res (2006) 1.16
A pilot study of impulsivity and compulsivity in pathological gambling. Psychiatry Res (2009) 1.15
Association of posttraumatic stress disorder with reduced in vivo norepinephrine transporter availability in the locus coeruleus. JAMA Psychiatry (2013) 1.14
Stability of intimate partner violence by men across 12 years in young adulthood: effects of relationship transitions. Prev Sci (2012) 1.13
Morphological and latency abnormalities of the mid-latency auditory evoked responses in schizophrenia: a preliminary report. Schizophr Res (2004) 1.13
Men's Aggression Toward Women: A 10-Year Panel Study. J Marriage Fam (2008) 1.12
Smoking expectancies, weight concerns, and dietary behaviors in adolescence. Pediatrics (2010) 1.12
Cognitive function and treatment response in a randomized clinical trial of computer-based training in cognitive-behavioral therapy. Subst Use Misuse (2011) 1.12
Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation. Int Clin Psychopharmacol (2006) 1.12
Relationship of nicotine dependence, subsyndromal and pathological gambling, and other psychiatric disorders: data from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry (2009) 1.12
Divergent neural substrates of inhibitory control in binge eating disorder relative to other manifestations of obesity. Obesity (Silver Spring) (2013) 1.11
Perfusion abnormalities and decision making in cocaine dependence. Biol Psychiatry (2004) 1.11
A preliminary study of sustained-release bupropion for smoking cessation in bipolar disorder. J Clin Psychopharmacol (2008) 1.11
Body mass index correlates negatively with white matter integrity in the fornix and corpus callosum: a diffusion tensor imaging study. Hum Brain Mapp (2011) 1.11
Heterogeneity in growth and desistance of alcohol use for men in their 20s: prediction from early risk factors and association with treatment. Alcohol Clin Exp Res (2012) 1.10
Impulse control disorders: clinical characteristics and pharmacological management. Ann Clin Psychiatry (2004) 1.09